Augmentation therapy of resistant postpartum depression with Aripiprazole

Trial Profile

Augmentation therapy of resistant postpartum depression with Aripiprazole

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Mar 2016

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Postnatal depression
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Mar 2016 Phase of the study changed from phase II to phase III, according to ClinicalTrials.gov record.
    • 16 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 04 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top